4//SEC Filing
Timothy Lu 4
Accession 0001209191-23-027782
CIK 0001645569other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:10 PM ET
Size
5.6 KB
Accession
0001209191-23-027782
Insider Transaction Report
Form 4
Timothy Lu
CMO
Transactions
- Sale
Common Stock
2023-05-03$36.54/sh−10,000$365,398→ 152,285 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 31, 2022.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $36.575 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
DICE Therapeutics, Inc.
CIK 0001645569
Entity typeother
Related Parties
1- filerCIK 0001880973
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:10 PM ET
- Size
- 5.6 KB